Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
The Journal of Pediatrics|April 1, 1994
Immunoglobulin A subclasses in infants' saliva and in saliva and milk from their mothersS P Fitzsimmons, M K Evans, C L Pearce, et al.Infection and Immunity|June 1, 1994
Pioneer oral streptococci produce immunoglobulin A1 proteaseM F Cole, M Evans, S Fitzsimmons, et al.Journal of Medical Microbiology|January 1, 1995
Identification of pioneer viridans streptococci in the oral cavity of human neonatesC Pearce, G H Bowden, M Evans, et al.American Journal of Epidemiology|March 1, 1989
Cardiovascular risk factor prevention in black schoolchildren: two-year results of the "Know Your Body" programP J Bush, A E Zuckerman, P K Theiss, et al.Virginia Medical Quarterly : VMQ|January 1, 1993
Stage I non-small cell cancer of the lung results of surgical resection at Fairfax HospitalP D Kiernan, M J Sheridan, W D Byrne, et al.Virginia Medical Quarterly : VMQ|January 1, 1993
Resection for esophageal carcinoma at a Virginia hospital 1981-1989P D Kiernan, M J Sheridan, W D Byrne, et al.Infection and Immunity|August 26, 1998
Humoral immunity to commensal oral bacteria in human infants: salivary antibodies reactive with Actinomyces naeslundii genospecies 1 and 2 during colonizationM F Cole, S Bryan, M K Evans, et al.Alimentary Pharmacology & Therapeutics|November 13, 2015
Longitudinal assessment of hepatitis C fibrosis progression by collagen and smooth muscle actin morphometry in comparison to serum markersK Patel, H L Tillmann, B Matta, et al.Infection and Immunity|March 20, 1999
Humoral immunity to commensal oral bacteria in human infants: salivary secretory immunoglobulin A antibodies reactive with Streptococcus mitis biovar 1, Streptococcus oralis, Streptococcus mutans, and Enterococcus faecalis during the first two years of lifeM F Cole, S Bryan, M K Evans, et al.Cancer Investigation|July 29, 1998
A comparison of efficacy of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in the therapeutic setting of chemotherapy-induced myelosuppressionR A Beveridge, J A Miller, A N Kales, et al.Pageof 4